Mar 13, 2026
Ro Khanna- Amount
- Receipt pending ingestion
- Filed
- Apr 7, 2026
Congress ticker disclosure profile
As of August 1 at 5:10 PM EDT
Public STOCK Act rows mentioning
A factual page for public Congressional disclosures that reference LCII. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.
90d rows
0
Feed lifetime
10
Member filers
4
Disclosed ranges
$8.0K
Most active member desks
6 sells vs 4 buys
Latest trade Mar 13, 2026
Mar 13, 2026
Ro KhannaFeb 13, 2026
Ro KhannaNov 14, 2025
Ro KhannaOct 27, 2025
Tony WiedDec 14, 2022
Michael T. McCaulApr 14, 2022
Michael T. McCaulJan 28, 2022
Michael T. McCaulDec 14, 2021
Michael T. McCaulMay 19, 2021
Michael T. McCaulMar 25, 2019
Nicholas Van Taylor| Date | Member | Action | Amount | Filed | Receipt |
|---|---|---|---|---|---|
| Mar 13, 2026 | Ro Khanna | Sell | Receipt pending ingestion | Apr 7, 2026 | Open card |
| Feb 13, 2026 | Ro Khanna | Sell | Receipt pending ingestion | Mar 9, 2026 | Open card |
| Nov 14, 2025 | Ro Khanna | Buy | Receipt pending ingestion | Dec 8, 2025 | Open card |
| Oct 27, 2025 | Tony Wied | Buy | Receipt pending ingestion | Nov 10, 2025 | Open card |
| Dec 14, 2022 | Michael T. McCaul | Sell | Receipt pending ingestion | Jan 19, 2023 | Open card |
| Apr 14, 2022 | Michael T. McCaul | Buy | Receipt pending ingestion | May 25, 2022 | Open card |
| Jan 28, 2022 | Michael T. McCaul | Sell | Receipt pending ingestion | Feb 23, 2022 | Open card |
| Dec 14, 2021 | Michael T. McCaul | Sell | Receipt pending ingestion | Jan 27, 2022 | Open card |
| May 19, 2021 | Michael T. McCaul | Buy | Receipt pending ingestion | Jun 17, 2021 | Open card |
| Mar 25, 2019 | Nicholas Van Taylor | Sell | $1,001 to $15,000 | Apr 15, 2019 | Open card |
Source creed
This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 1 of 10 filed rows include disclosed amount ranges (10%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.
Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.